
David Finkelshteyn
@davidf_ai
CEO | AI Drug Innovation, LLMs & MVP Development, Data-Driven Software Solutions, Big Data, Cloud Systems, and Scalable AI Solutions
ID: 1800823468948414464
https://pivot-al.ai/ 12-06-2024 09:32:39
201 Tweet
130 Takipçi
905 Takip Edilen







$42M Raised: Illimis Therapeutics Therapeutics Advances Alzheimer's Treatment! Seoul-based biotech startup Illimis Therapeutics has secured 58 billion won ($42 million) in a Series B round led by Korean venture capital firm DSC Investment. The investment brings the company's total funding







$1M Received: Tevogen Bio Accelerates AI-Driven Drug Discovery! US-based biotech company Tevogen Bio (Nasdaq: $TVGN) has received $1 million in funding from KRHP LLC to advance its Tevogen.AI platform. This is part of a larger agreement that could provide up to $10
